latest news releases from the newsroom
Lantronix to Present at Roth Capital Partners 17th Annual 2005 Growth Stock Conference
IRVINE, Calif., Feb. 18, 2005 (PRIMEZONE) -- Lantronix (Nasdaq:LTRX) today announced that the company management will make a presentation at the Roth Capital Partners 17th Annual Growth Stock Conference at the St. Regis Monarch Beach Resort and Spa in Dana Point, California on Wednesday, February 23, 2005 at approximately 11:00AM Pacific Time. The conference provides an opportunity for management to address investors and other interested persons.
U.S. BioDefense Cordially Invited by Canadian Consulate to Attend the Internationalizing Early-Stage Clinical Drug Research & Development Conference
CITY OF INDUSTRY, Calif., Feb. 18, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE) announces that they will be attending the Internationalizing Early-Stage Clinical Drug Research & Development Conference, being hosted at The Stadium Club at Dodger Stadium in Los Angeles, CA on Thursday, March 3rd, 2004. Panelists (http://www.losangeles.gc.ca/) include Mr. David Mee of Amgen (Nasdaq:AMGN), Dr. Bruce Morimoto of MDS Pharma Services, and Dr. Jim Gallivan of Health Canada.
Haldex wins Large Compressor Business
STOCKHOLM, Sweden, Feb. 18, 2005 (PRIMEZONE) -- Haldex Air Management Division (a part of the Commercial Vehicle Systems business area) has signed a contract with a major global diesel engine manufacturer to supply truck brake system air compressors for their North American production. Deliveries are planned to begin late in 2005 and the order value is estimated to exceed 500 MSEK ($75 m.) over the life of the contract.
Delhaize Group Sells its Slovak Stores to Rewe
BRUSSELS, Belgium, Feb. 18, 2005 (PRIMEZONE) -- Delhaize Group (Euronext Brussels:DELB) (NYSE:DEG), the Belgian international food retailer, announced today that Delvita SK, its Slovak subsidiary, has reached a binding agreement to sell its 11 Slovak stores to the German retailer Rewe Group for EUR 7.7 million (excluding inventories).
Actelion Provides Update on Bosentan in Japan
ALLSCHWIL, Switzerland, Feb. 18 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) today announced that the Japanese Health Authority (MHLW) have informed the company that the upcoming next drug evaluation committee session will formally review the marketing application for bosentan (Tracleer(r)) for the indication Pulmonary Arterial Hypertension. The review meeting is scheduled for 25 February 2005. In case of a favorable review, Actelion expects that it could commercially introduce Tracleer(r) in Japan in spring 2005.